Advertisement

Gesamtübersicht

Dementiell-depressives Syndrom bei Chorea Huntington

Zeitschrift: Nervenheilkunde
ISSN: 0722-1541
Thema:

Aktuelles aus Klinik und Praxis aus dem Universitätsklinikum Ulm

Ausgabe: 2017: Heft 9 2017 (683-782)
Seiten: 735-738

  1. Trottier Y, Biancalana V, Mandel JL. Instability of CAG repeats in Huntington’s disease: relation to parental transmission and age of onset. J Med Genet 1994; 31 (5): 377-82. DOI:10.1136/jmg.31.5.377
  2. Warby SC, Visscher H, Collins JA, Doty CN, Carter C, Butland SL et al. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet 2011; 19 (5): 561-6. DOI:10.1038/ejhg.2010.229
  3. Novak MJU, Tabrizi SJ. Huntington’s disease: clinical presentation and treatment. Int Rev Neurobiol 2011; 98: 297-323.
  4. Paulsen JS. Cognitive impairment in Huntington Disease: Diagnosis and treatment. Curr Neurol Neurosci Rep 2011; 11 (5): 474-83. DOI:10.1007/s11910-011-0215-x
  5. Roos RAC. Huntington’s disease: a clinical review. Orphanet J Rare Dis 2010; 5 (1): 40. DOI:10.1186/1750-1172-5-40
  6. van Duijn E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiatry Clin Neurosci 2007; 19 (4): 441-8. DOI:10.1176/jnp.2007.19.4.441
  7. Ho AK, Gilbert AS, Mason SL, Goodman AO, Barker RA. Health-related quality of life in Huntington’s disease: Which factors matter most? Mov Disord 2009; 24 (4): 574-8. DOI:10.1002/mds.22412
  8. Nehl C, Paulsen JS, Huntington Study Group. Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity. J Nerv Ment Dis 2004; 192 (1): 72-4. DOI:10.1097/01.nmd.0000106004.67587.57
  9. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC, Predict-HD Investigators of the Huntington Study Group. Psychiatric Symptoms in Huntington’s Disease before Diagnosis: The Predict-HD Study. Biol Psychiatry 2007; 62 (12): 1341-6. DOI:10.1016/j.biopsych.2006.11.034
  10. Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJW et al. The Prevalence of Huntington’s Disease. Neuroepidemiology 2016; 46 (2): 144-53. DOI:10.1159/000443738
  11. van Duijn E, Craufurd D, Hubers AAM, Giltay EJ, Bonelli R, Rickards H et al. Neuropsychiatric symptoms in a European Huntington’s disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry 2014; 85 (12): 1411-8. DOI:10.1136/jnnp-2013-307343
  12. Berrios GE, Wagle AC, Marková IS, Wagle SA, Ho LW, Rubinsztein DC et al. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington’s disease gene carriers. Psychiatry Res 2001; 102 (3): 217-25. DOI:10.1016/S0165-1781(01)00257-8
  13. Shiwach R. Psychopathology in Huntington’s disease patients. Acta Psychiatr Scand 1994; 90 (4): 241-6. DOI:10.1111/j.1600-0447.1994.tb01587.x
  14. Julien CL et al. Psychiatric disorders in preclinical Huntington’s disease. J Neurol Neurosurg Psychiatry 2007; 78 (9): 939-43. DOI:10.1136/jnnp.2006.103309
  15. Paulsen JS, Smith MM, Long JD, PREDICT HD investigators and Coordinators of the Huntington Study Group. Cognitive decline in prodromal Huntington Disease: implications for clinical trials. J Neurol Neurosurg Psychiatry 2013; 84 (11): 1233-9. DOI:10.1136/jnnp-2013-305114
  16. Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW. Executive and mnemonic functions in early Huntington’s disease. Brain 1996; 1633-45
  17. Verny C et al. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol 2007; 14 (12): 1344-50. DOI:10.1111/j.1468-1331.2007.01975.x
  18. Paulsen J et al. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology 1995; 45 (5): 951-6. DOI:10.1212/WNL.45.5.951
  19. Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009; 84 (3): 351-66. DOI:10.1016/j.ajhg.2009.02.003
  20. Goldberg YP, Kremer B, Andrew SE, Theilmann J, Graham RK, Squitieri F et al. Molecular analysis of new mutations for Huntington’s disease: intermediate alleles and sex of origin effects. Nat Genet 1993; 5 (2): 174-9. DOI:10.1038/ng1093-174
  21. Goldberg YP, McMurray CT, Zeisler J, Almqvist E, Sillence D, Richards F et al. Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum Mol Genet 1995; 4 (10): 1911-8. DOI:10.1093/hmg/4.10.1911
  22. Kremer B et al. A worldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994; 330 (20): 1401-6. DOI:10.1056/NEJM199405193302001
  23. Semaka A, Collins JA, Hayden MR. Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles). Am J Med Genet B Neuropsychiatr Genet 2010; 153B(1): 314-20
  24. Semaka A et al. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. J Med Genet 2013; 50 (10): 696-703. DOI:10.1136/jmedgenet-2013-101796
  25. Bellotti R, De Carlo F, Massafra R, de Tommaso M, Sciruicchio V. Topographic classification of EEG patterns in Huntington’s disease. Neurol Clin Neurophysiol 2004: 37
  26. Piano C et al. Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature. Clin EEG Neurosci 2017; 48 (1): 60-71. DOI:10.1177/1550059416632413
  27. Vogel F, Wendt GG, Oepen H. Das EEG und das Problem einer Frühdiagnose der Chorea Huntington. Dtsch Z Nervenheilkd 1961; 182 (4): 355-61.

Artikel, die Sie auch interessant finden könnten...

1.
H. Förstl

Die Psychiatrie 2008 5 1: 13-17

2.
P. Kermer

Die Medizinische Welt 2007 58 10: 482-485

3.
F. Erbguth, W. Dietrich

Nervenheilkunde 2007 26 9: 759-762



Nervenheilkunde 11/2017: Soteria

„Soteria“ entstand als Alternative zur psychiatrischen Klinikbehandlung in den 1960er- und...

Psychologen in der Psychiatrie: Geschichte der Klinischen Psychologie in der Bundesrepublik Deutschland

Die Entwicklung der modernen Psychiatrie und der Klinischen Psychologie ist – zumindest in Teilen –...

Nervenheilkunde 09/2017: Metabolische Nebenwirkungen der Psychopharmakotherapie

Psychopharmaka stellen oft eine erhebliche Belastung für die Patienten dar. Unerwünschte...